Hims & Hers New Growth Category Is a Huge Surprise
Hims & Hers (NYSE: HIMS) announced this week that it's getting into the nutrition business with bars and shakes. But are these the right products to add to a pharmaceutical business? Travis Hoium breaks down the news and how this fits into Hims & Hers' business in this video.
*Stock prices used were end-of-day prices of Nov. 21, 2024. The video was published on Nov. 21, 2024.
Don’t miss this second chance at a potentially lucrative opportunity
Ever feel like you missed the boat in buying the most successful stocks? Then you’ll want to hear this.
On rare occasions, our expert team of analysts issues a “Double Down” stock recommendation for companies that they think are about to pop. If you’re worried you’ve already missed your chance to invest, now is the best time to buy before it’s too late. And the numbers speak for themselves:
- Nvidia: if you invested $1,000 when we doubled down in 2009, you’d have $380,291!*
- Apple: if you invested $1,000 when we doubled down in 2008, you’d have $43,278!*
- Netflix: if you invested $1,000 when we doubled down in 2004, you’d have $484,003!*
Right now, we’re issuing “Double Down” alerts for three incredible companies, and there may not be another chance like this anytime soon.
*Stock Advisor returns as of November 18, 2024
Travis Hoium has positions in Hims & Hers Health. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. Travis Hoium is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through their link they will earn some extra money that supports their channel. Their opinions remain their own and are unaffected by The Motley Fool.
